A global health company offering medical insurance through Cigna Healthcare and pharmacy and care services through Evernorth, home to brands like Express Scripts, Accredo, and MDLive. It was born from the 1982 merger of Connecticut General Life Insurance and Insurance Company of North America — and the name "Cigna" simply stitches the C and INA initials together. Its oldest ancestor, INA, dates to 1792 as America's first marine insurer.
Cigna reaffirms 2026 adjusted EPS outlook of at least $30.35 per share
The Cigna Group expects to reaffirm its full year 2026 consolidated adjusted income from operations per share outlook of at least $30.35 during upcoming investor and analyst meetings.
Show detailsHide details
The outlook was previously disclosed in an April 30, 2026 press release and related investor conference call.
Adjusted income from operations is a non-GAAP measure that excludes net investment gains/losses, amortization of acquired intangible assets, and special items.
Management cannot provide a forward-looking reconciliation to GAAP shareholders' net income due to uncertainty in future net investment results and special items.
The disclosure is furnished under Item 7.01 Regulation FD and is not deemed filed for SEC purposes.
Cigna appoints Brian Evanko as CEO, effective July 1, 2026; Cordani to become Executive Chair
Evanko will be elected to the Board effective April 1, 2026, and will not receive separate compensation for board service.
Show detailsHide details
Brian C. Evanko, currently President and COO, will become CEO of The Cigna Group effective July 1, 2026.
David M. Cordani will retire as CEO effective July 1, 2026, and will serve as Executive Chair of the Board.
As CEO, Evanko's base salary will be $1.3 million, with EIP target of $2.6 million and LTI target of $15.1 million, plus a one-time transitional equity award of $3.5 million.
The company reaffirmed its 2026 outlook: consolidated adjusted income from operations of at least $30.25 per share.
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits
Cigna reaffirms 2026 adjusted income outlook of at least $30.25 per share
The outlook was previously disclosed in a press release dated February 5, 2026, and during the related investor conference call.
Show detailsHide details
The Cigna Group expects to reaffirm its full year 2026 consolidated adjusted income from operations per share outlook of at least $30.25 during upcoming investor and analyst meetings.
Adjusted income from operations is a non-GAAP measure that excludes net investment gains/losses, amortization of acquired intangible assets, and special items.
Management cannot provide a reconciliation of the forward-looking adjusted income measure to GAAP net income due to the unpredictability of future investment results and special items.
The information is furnished under Item 7.01 and is not deemed filed for SEC purposes.
Cigna Board approves committee structure changes effective January 1, 2026.
The Compliance Committee will cease as a separate standing committee, with its responsibilities assumed by the Board and other committees.
Show detailsHide details
On October 22, 2025, The Cigna Group's Board approved changes to its committee structure, effective January 1, 2026.
The Audit Committee will be renamed the 'Audit and Compliance Committee' to oversee enterprise compliance matters.
The Corporate Governance Committee will assume oversight of the ethics program and public clinical reporting.
The Finance Committee will be renamed the 'Finance and Technology Committee' to consolidate technology oversight, including AI and information security.